AI methods for automated identification of regions of inflammation from ⁹⁹ᵐTc-Maraciclatide imaging presented at the World Molecular Imaging Congress 2023

London, UK, 9 September 2023. Serac Healthcare Limited (“Serac Healthcare” or “the Company”), a clinical radiopharmaceutical company developing innovative molecular imaging technologies, announces that a poster titled “Automatic segmentation of regions of inflammation using deep neural networks for ⁹⁹ᵐTc-Maraciclatide gamma camera imaging of rheumatoid arthritis” is being presented at the World Molecular Imaging Society meeting taking place from 5 to 9 September in Prague, Czech Republic.

Share this article with a friend

Create an account to access this functionality.
Discover the advantages